Drugs in Dev. Infections and Infectious Diseases
Discovery
China 
Lead Product(s) : BAT2022,VHH18. 2F8
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Discovery
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Bio-Thera Solutions Reported the Discovery of a SARS-CoV-2 Neutralizing Antibody
Details : BAT2022 demonstrated potent in vivo efficacy against SARS-CoV-2 in a mice model both prophylactically and therapeutically, protecting animals from disease progress and abolishing virus replication in the lungs.
Product Name : BAT2022
Product Type : Antibody
Upfront Cash : Inapplicable
November 08, 2021
Lead Product(s) : BAT2022,VHH18. 2F8
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Discovery
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Undisclosed
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Discovery
Sponsor : Evotec
Deal Size : Undisclosed
Deal Type : Collaboration
HitGen and Evotec SE Enter Into Drug Discovery Research Collaboration
Details : HitGen will apply its platform technology, based on the design, synthesis and screening of DNA-encoded libraries (DEL) to identify small molecule leads against targets of interest to Evotec SE in the field of anti-infectives.
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Undisclosed
August 06, 2020
Lead Product(s) : Undisclosed
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Discovery
Sponsor : Evotec
Deal Size : Undisclosed
Deal Type : Collaboration
Reset All
